Centese

United States
Fruitport, Michigan, United States, 68117

Company profile

Centese company profile

Centese is a medical device company that develops Thoraguard, a reliable surgical drainage system. Using digital intelligence, Thoraguard revolutionizes operative drainage in cardiothoracic surgery. Thoraguard is a digital technology that provides accurate data monitoring and automatic chest tube clearing with the goal of enhancing clinical judgment and patient safety. Centese is committed to delivering improved post-operative surgical drainage solutions that are designed for safety, intelligence, and effectiveness in order to enhance results and save costs in cardiothoracic surgery.

Business identity

Phone number
402-417-0740
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2015-01-01, Year

Headquarters

Postal code
68117
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
6
Total equity funding
$19.9M
Last funding
Series B / $15M / 2023-11-21
Last equity funding
Series B / $15M
Investors
3
Lead investors
2
Founders
1
Articles
10

Founders and investors

Founders

Evan Luxon

Lead investors

MedTech Venture PartnersNational Science Foundation

Investors

Invest NebraskaMedTech Venture PartnersNational Science Foundation